NCT00959842View on ClinicalTrials.gov

Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Hypertriglyceridemia
Interventions
DRUG

Lovaza

1 gram gel capsule 4 capsules per day for 8 weeks

Trial Locations (1)

57105

Sanford Research/USD, Sioux Falls

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Sanford Research

OTHER